{
    "clinical_study": {
        "@rank": "132668", 
        "arm_group": [
            {
                "arm_group_label": "2.5 units oxytocin", 
                "arm_group_type": "Active Comparator", 
                "description": "Administration of 2.5 units of oxytocin intravenously after clamping of umbilical cord"
            }, 
            {
                "arm_group_label": "10 units oxytocin", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Administration of 10 units of oxytocin after clamping of umbilical cord"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study was to determine whether 2.5 international units of oxytocin gives\n      adequate uterine tone and is safe as compared to 10 international units of oxytocin\n      following caesarean section delivery at Mulago hospital."
        }, 
        "brief_title": "Uterotonic Efficacy of Oxytocin 2.5 Versus 10 Units During Caesarean Section at Mulago Hospital", 
        "completion_date": {
            "#text": "April 2011", 
            "@type": "Actual"
        }, 
        "condition": [
            "Adverse Effect of Oxytocic Drugs", 
            "Uterine Hemorrhage", 
            "Inappropriate Dose of Drug Administered"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Uterine Hemorrhage"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  ASA I (Healthy patient with no systemic disease) or  II ( mild to    moderate\n             systemic disease)\n\n          -  Age between 18 to 40 years\n\n          -  Singleton pregnancies\n\n        Exclusion Criteria:\n\n          -  \u2022 Allergy to oxytocin\n\n               -  Ruptured uterus\n\n               -  Significant obstetric disease (including Pregnancy induced Hypertension,\n                  Eclampsia,)\n\n               -  Known risk factors for postpartum haemorrhage or uterine atony\n\n               -  Inherited or acquired coagulation disorder\n\n               -  History of post partum haemorrhage"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "40 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "386", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01726478", 
            "org_study_id": "OXY168"
        }, 
        "intervention": [
            {
                "arm_group_label": "2.5 units oxytocin", 
                "description": "Administration of 2.5 units of oxytocin after clamping of umbilical cord", 
                "intervention_name": "2.5 units Oxytocin", 
                "intervention_type": "Drug", 
                "other_name": "pitocin"
            }, 
            {
                "arm_group_label": "10 units oxytocin", 
                "description": "Administration of 10 units of oxytocin after clamping of umbilical cord", 
                "intervention_name": "10 units Oxytocin", 
                "intervention_type": "Drug", 
                "other_name": "pitocin"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Oxytocin"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Oxytocin", 
            "Uterine tone", 
            "Mulago Hospital", 
            "Dose", 
            "Side effects"
        ], 
        "lastchanged_date": "November 9, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Kampala", 
                    "country": "Uganda", 
                    "state": "East Africa", 
                    "zip": "+256"
                }, 
                "name": "Mulago Hospital Labour Suite Operating Theatres"
            }
        }, 
        "location_countries": {
            "country": "Uganda"
        }, 
        "number_of_arms": "2", 
        "official_title": "Uterotonic Efficacy of Oxytocin 2.5 Versus 10 Units During Caesarean Section at Mulago Hospital; Adouble Blinded Clinical Trial.", 
        "overall_official": {
            "affiliation": "Makerere University College of Health Sciences Department of Anaesthesia", 
            "last_name": "Andrew Kintu, MBChB", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Uganda: National Council for Science and Technology", 
                "Uganda: Research Ethics Committee", 
                "Uganda: Ministry of Health"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The primary outcome was the assessment of either adequate or inadequate Uterine tone at various times after administration of initial oxytocin dose", 
            "measure": "Uterine tone adequacy", 
            "safety_issue": "Yes", 
            "time_frame": "2 minutes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01726478"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Makerere University", 
            "investigator_full_name": "Faculty of Medicine", 
            "investigator_title": "Dr Andrew Kintu", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "Blood loss was estimated by measuring the amount in the suction bottles and weighing of the mops. The patients were followed up for any occurrence of postpartum haemorrhage for the next 24 hours after surgery.", 
            "measure": "Intraoperative blood loss", 
            "safety_issue": "Yes", 
            "time_frame": "24 hours"
        }, 
        "source": "Makerere University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Faculty of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}